| Hallmarks of glycosylation in cancer J Munkley, DJ Elliott Oncotarget 7 (23), 35478, 2016 | 530 | 2016 |
| The role of sialyl-Tn in cancer J Munkley International journal of molecular sciences 17 (3), 275, 2016 | 226 | 2016 |
| EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia V Boczonadi, JS Müller, A Pyle, J Munkley, T Dor, J Quartararo, I Ferrero, ... Nature communications 5 (1), 4287, 2014 | 154 | 2014 |
| ST6GAL1: A key player in cancer R Garnham, E Scott, KE Livermore, J Munkley Oncology letters 18 (2), 983-989, 2019 | 148 | 2019 |
| Glycans as biomarkers in prostate cancer E Scott, J Munkley International journal of molecular sciences 20 (6), 1389, 2019 | 135 | 2019 |
| The glycosylation landscape of pancreatic cancer J Munkley Oncology Letters 17 (3), 2569-2575, 2019 | 130 | 2019 |
| FUT8 alpha-(1, 6)-fucosyltransferase in cancer K Bastian, E Scott, DJ Elliott, J Munkley International Journal of Molecular Sciences 22 (1), 455, 2021 | 125 | 2021 |
| The role of glycans in the development and progression of prostate cancer J Munkley, IG Mills, DJ Elliott Nature Reviews Urology 13 (6), 324-333, 2016 | 124 | 2016 |
| Targeting aberrant sialylation to treat cancer J Munkley, E Scott Medicines 6 (4), 102, 2019 | 96 | 2019 |
| Glycosylation is an androgen-regulated process essential for prostate cancer cell viability J Munkley, D Vodak, KE Livermore, K James, BT Wilson, B Knight, ... EBioMedicine 8, 103-116, 2016 | 94 | 2016 |
| The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer J Munkley, S Oltean, D Vodák, BT Wilson, KE Livermore, Y Zhou, E Star, ... Oncotarget 6 (33), 34358, 2015 | 82 | 2015 |
| Alternative splicing in lung cancer AO Coomer, F Black, A Greystoke, J Munkley, DJ Elliott Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1862 (11-12 …, 2019 | 81 | 2019 |
| Aberrant sialylation in cancer: therapeutic opportunities J Munkley Cancers 14 (17), 4248, 2022 | 71 | 2022 |
| RNA splicing and splicing regulator changes in prostate cancer pathology J Munkley, K Livermore, P Rajan, DJ Elliott Human genetics 136, 1143-1154, 2017 | 68 | 2017 |
| Glycosylation is a global target for androgen control in prostate cancer cells J Munkley Endocrine-Related Cancer 24 (3), R49-R64, 2017 | 66 | 2017 |
| Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer DJE J Munkley, Ling Li, Krishnan SRG, Hysenaj G, Scott E, Oo HZ, Maja T ... eLife 8, e47678, 2019 | 63 | 2019 |
| The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration J Munkley, UL McClurg, KE Livermore, I Ehrmann, B Knight, P Mccullagh, ... Scientific reports 7 (1), 5249, 2017 | 53 | 2017 |
| Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells J Munkley, NP Lafferty, G Kalna, CN Robson, HY Leung, P Rajan, ... BMC cancer 15, 1-11, 2015 | 49 | 2015 |
| The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells J Munkley, KE Livermore, UL McClurg, G Kalna, B Knight, P McCullagh, ... Oncoscience 2 (9), 755, 2015 | 39 | 2015 |
| Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth E Scott, K Hodgson, B Calle, H Turner, K Cheung, A Bermudez, ... Oncogene 42 (12), 926-937, 2023 | 37 | 2023 |